Super. Yes, I agree. I was not happy about the VLA takeover from Merck but there is no comparison here. They were a one trick pony and not presenting the kind of potential that Imugene has come up with so far. Hard to compare. Maybe Paul Hopper was happy to get out and concentrate on bigger prospects like Imugene?
Ann: CEO and Managing Director increases shareholding in Imugene, page-60
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.001(2.08%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $93.42K | 1.919M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 7631372 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2885344 | 22 |
View Market Depth
| Last trade - 10.59am 04/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |